Cat#:CTLA4-028HAC;Product Name:Recombinant Cynomolgus / Rhesus macaque CTLA-4(Avi Tag), Biotinylated;Synonym:CTLA4,GRD4,GSE,ICOS,IDDM12, CD152,CELIAC3;Description:Biotinylated recombinant Cynomolgus / Rhesus macaque CTLA-4 is produced in HEK293 cells. It contains AA Ala 37 - Ser 160.;Source:HEK293;Predicted N Terminal:Ala 37;Molecular Characterization:The recombinant human CTLA-4 protein has a calculated molecular weight of 15.9 kDa. The human CTLA-4 protein migrates as 23-26 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation.;Purity:Greater than 92% as determined by SDS-PAGE.;Endotoxin:<1.0 EU per μg of recombinant human CTLA-4 protein by the LAL method.;Formulation:Recombinant human CTLA-4 protein was lyophilized from 0.22 μm filtered solution in PBS, pH7.4.;Stability:Recombinant human CTLA-4 protein was stable up to 1 year from date of receipt at -70℃;Reconstitution:See related COA;Storage:Store recombinant human CTLA-4 protein under sterile conditions at -20℃ to -80℃. It is recommended that the recombinant protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.;Usage:For Lab Research Use Only;
Biotinylated recombinant Cynomolgus / Rhesus macaque CTLA-4 is produced in HEK293 cells. It contains AA Ala 37 - Ser 160.
Source:
HEK293
Predicted N Terminal:
Ala 37
Molecular Characterization:
The recombinant human CTLA-4 protein has a calculated molecular weight of 15.9 kDa. The human CTLA-4 protein migrates as 23-26 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation.
Purity:
Greater than 92% as determined by SDS-PAGE.
Endotoxin:
<1.0 EU per μg of recombinant human CTLA-4 protein by the LAL method.
Formulation:
Recombinant human CTLA-4 protein was lyophilized from 0.22 μm filtered solution in PBS, pH7.4.
Stability:
Recombinant human CTLA-4 protein was stable up to 1 year from date of receipt at -70℃
Reconstitution:
See related COA
Usage:
For Lab Research Use Only
Storage:
Store recombinant human CTLA-4 protein under sterile conditions at -20℃ to -80℃. It is recommended that the recombinant protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.